Skip Navigation

This Article
Right arrow Full Text Freely available
Right arrow FREE Full Text (PDF) Freely available
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in ISI Web of Science
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Add to My Personal Archive
Right arrow Download to citation manager
Right arrow Search for citing articles in:
ISI Web of Science (7)
Right arrowRequest Permissions
Right arrow Disclaimer
Google Scholar
Right arrow Articles by Kim, Y.-G.
Right arrow Articles by Oh, H.-Y.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Kim, Y.-G.
Right arrow Articles by Oh, H.-Y.
Social Bookmarking
 Add to CiteULike   Add to Connotea   Add to Del.icio.us  
What's this?

Nephrol Dial Transplant (2001) 16: 2303-2309
© 2001 European Renal Association-European Dialysis and Transplant Association


Rapid Communication

Medullary nephrocalcinosis associated with long-term furosemide abuse in adults

Yoon-Goo Kim1, Bohyun Kim2, Mi-Kyung Kim3, Shi-Jung Chung1, Hyeok-Jun Han1, Jeong-Ah Ryu2, Yoon-Ha Lee1, Kyu-Beck Lee1, Jee Yun Lee1, Wooseong Huh1 and Ha-Young Oh1,

1 Department of Nephrology, 2 Department of Diagnostic Radiology and 3 Department of Diagnostic Pathology, Samsung Medical Center, Sunkyunkwan University School of Medicine, Seoul, Korea

Abstract

Background. The use of furosemide is well recognized as a predisposing factor of nephrocalcinosis in infants. Although furosemide is widely used for various medical conditions in adults, its association with nephrocalcinosis in adults is not well established.

Methods. We studied 18 consecutive adult patients (male:female ratio 1:17, age range 21–59 years) who habitually took furosemide to control weight or oedema for long periods of time (range 3–25 years). The daily dose of continuous intake of furosemide ranged from 40 to 2800 mg. Nephrocalcinosis was evaluated using renal ultrasonography (US), computed tomography (CT), or kidney biopsies.

Results. Renal US and CT revealed bilateral nephrocalcinosis of the medullary pyramids in 15 (83.3%) out of 18 patients. The duration of furosemide abuse was similar between nephrocalcinosis positive (NC(+)) and nephrocalcinosis negative (NC(-)) groups. The daily dose of furosemide was nearly 10 times higher in the NC(+) group (range 120–2800 mg, mean 538 mg) than the NC(-) group (range 40–80 mg, mean 67 mg). All patients showed variable degrees of renal insufficiency and there was no difference in creatinine clearance between the NC(+) and NC(-) groups (P>0.05). Kidney biopsies performed in three patients showed focal tubulo-interstitial fibrosis and atrophy and calcifications were observed in outer medullary tubulo-interstitium.

Conclusions. Long-term furosemide abuse can cause medullary nephrocalcinosis in adults, and the risk of developing of nephrocalcinosis seems to be correlated with the daily dose of furosemide. We suggest that long-term furosemide abuse should be suspected in adult patients when medullary nephrocalcinosis is incidentally detected by US or CT.

Keywords: adult; computed tomography; furosemide; nephrocalcinosis; ultrasonography

Notes

Correspondence and offprints requests to: Ha-Young Oh, MD, Department of Nephrology, Samsung Medical Center, Sungkyunkwan University School of Medicine, 50 Irwon Dong, Kangnam Ku, Seoul, 135–710, Korea. Email: ygkim{at}smc.samsung.co.kr


Add to CiteULike CiteULike   Add to Connotea Connotea   Add to Del.icio.us Del.icio.us    What's this?




Disclaimer:
Please note that abstracts for content published before 1996 were created through digital scanning and may therefore not exactly replicate the text of the original print issues. All efforts have been made to ensure accuracy, but the Publisher will not be held responsible for any remaining inaccuracies. If you require any further clarification, please contact our Customer Services Department.